4,7-Dibromo-1,3-dihydro-2H-benzo[d]imidazol-2-one

Catalog No. :
ACCJBY476
CAS No. :
69272-52-2
Molecular Formula :
C7H4Br2N2O
Molecular Weight :
291.93

IUPAC Name:4,7-dibromo-1,3-dihydro-2H-benzo[d]imidazol-2-one

4,7-Dibromo-1,3-dihydro-2H-benzo[d]imidazol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$103.00Login to see priceIn stockInquiry
50mg98%$169.00Login to see priceIn stockInquiry
100mg98%$287.00Login to see priceIn stockInquiry
250mg98%$508.00Login to see priceIn stockInquiry
1g98%$1327.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,7-Dibromo-1,3-dihydro-2H-benzo[d]imidazol-2-one
IUPAC Name4,7-dibromo-1,3-dihydro-2H-benzo[d]imidazol-2-one
MDL No.MFCD28579339
Molecular FormulaC7H4Br2N2O
Molecular Weight291.93
SMILESO=C1NC2=C(Br)C=CC(Br)=C2N1
InChI KeyHMZICMLGPYLZJN-UHFFFAOYSA-N
Synonym4,7-Dibromo-1,3-dihydro-benzoimidazol-2-one;4,7-dibromo-1H-benzo[d]imidazol-2(3H)-one;2H-Benzimidazol-2-one, 4,7-dibromo-1,3-dihydro-;4,7-dibromo-1,3-dihydro-2H-benzo[d]imidazol-2-one;4,7-Dibromo-1,3-dihydro-2H-benzimidazol-2-one - [AC80299]
CAS No.69272-52-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACCJBY476 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVAPG960 route compound structure diagram
    ACVAPG96069272-50-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCJBY476 route product structure diagram
    ACCJBY47669272-52-2 In Stock
Inquiry

2. ACCJBY476 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCJBY476 route product structure diagram
    ACCJBY47669272-52-2 In Stock
Inquiry

Comments (0)